| Drug NDC: | 63479-0307 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. | |
| Proprietary Name: | C07 Strong Ligaments And Joints |
| Also known as the trade name. It is the name of the product chosen by the labeler. | |
| Proprietary Name Base: | C07 |
| The base of the Brand/Proprietary name excluding its suffix. | |
| Proprietary Name Suffix: | STRONG LIGAMENTS AND JOINTS |
| A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard. | |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. | |
| Non Proprietary Name: | Arnica Montana, Ascorbicum Acidum, Bos Taurus Lymph Vessel, Intervertebral Fibrocartilage, Bos Taurus Mesenchyme, Calcarea Phosphorica, Cartilago Suis, Formicum Acidum, Lapis Albus, Pinus Montana Leafy Twig, Rhamnus Californica, Rhus Toxicodendron, Ruta Graveolens, Silicea, Sus Scrofa Joint Envelope, Sus Scrofa Ligament, Sus Scrofa Meniscus, Sus Scrofa Parathyroid Gland, Sus Scrofa Vein, Symphytum Officinale |
| Also known as the generic name, this is usually the active ingredient(s) of the product. | |
| Labeler Name: | Apex Energetics Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. | |
| Dosage Form: | Solution/ Drops |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. | |
| Substance Name: | ARNICA MONTANA - 12 [hp_X]/mL ASCORBIC ACID - 8 [hp_X]/mL BOS TAURUS INTERVERTEBRAL DISC - 8 [hp_C]/mL BOS TAURUS LYMPH VESSEL - 7 [hp_C]/mL BOS TAURUS MESENCHYME - 8 [hp_C]/mL CALCIUM HEXAFLUOROSILICATE - 12 [hp_X]/mL COMFREY ROOT - 9 [hp_X]/mL FORMIC ACID - 12 [hp_X]/mL FRANGULA CALIFORNICA BARK - 8 [hp_X]/mL PINUS MUGO LEAFY TWIG - 7 [hp_X]/mL Load more... RUTA GRAVEOLENS FLOWERING TOP - 12 [hp_X]/mL SILICON DIOXIDE - 12 [hp_X]/mL SUS SCROFA CARTILAGE - 7 [hp_C]/mL SUS SCROFA JOINT CAPSULE - 8 [hp_C]/mL SUS SCROFA LIGAMENT - 8 [hp_C]/mL SUS SCROFA MENISCUS - 7 [hp_C]/mL SUS SCROFA PARATHYROID GLAND - 8 [hp_C]/mL SUS SCROFA VEIN - 7 [hp_C]/mL TOXICODENDRON PUBESCENS LEAF - 15 [hp_X]/mL TRIBASIC CALCIUM PHOSPHATE - 12 [hp_X]/mL |
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. | |
| Route Details: | SUBLINGUAL |
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Start Date: | 15 Aug, 1988 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. | |
| Marketing End Date: | 20 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. | |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. | |
| Manufacturer Name: | Apex Energetics Inc. |
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. | |
| Original Packager: | Yes |
| Whether or not the drug has been repackaged for distribution. | |
| UPC: | 0818960011734 |
| UPC stands for Universal Product Code. | |
| NUI: | N0000193618 M0001797 |
| Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT). | |
| UNII: | O80TY208ZW PQ6CK8PD0R 0A04Z76C13 85I1Z426OV 3802H34QRI 2NVP93XVQ3 M9VVZ08EKQ 0YIW783RG1 1LZ13MQR0S 787BZ3D14H Load more... N94C2U587S ETJ7Z6XBU4 73ECW5WG2F LX0XHE5NLN 2004Q810JO 1C8T78BD9Q 2KBE35NE8S 2510RH3I89 6IO182RP7A 91D9GV0Z28 |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. | |
| Pharmacologic Class EPC: | Vitamin C [EPC] |
| Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`. | |
| Pharmacologic Class CS: | Ascorbic Acid [CS] |
| Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient]. | |
| Pharmacologic Class: | Ascorbic Acid [CS] Vitamin C [EPC] |
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. | |
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|---|---|---|---|
| 63479-0307-1 | 30 mL in 1 BOTTLE, GLASS (63479-0307-1) | 15 Aug, 1988 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. | ||||
* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.